Although COVID-19 vaccines help reduce the spread of COVID-19 and resulting deaths, there have not been many good or easy treatment options for the actual virus. But a new antiviral drug from Merck offers hope for keeping patients infected with COVID-19 out of the hospital and alive. Dr. Nahid Bhadelia, an infectious disease specialist at Boston University, joins William Brangham to discuss.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts